Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903326 · ClinicalTrials.gov registry record
Dexmedetomidine as a Sole Premedication for BMT Placement
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 276
- Enrollment target
NCT05903326: Completed study, sponsored by Nemours Children's Clinic.
NCT05903326 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 276 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05903326 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
There is very little evidence or research documenting any single method of sedation/analgesia for myringotomy tube (BMT) placement as being more effective than others. This was a retrospective chart review conducted to determine if there were significant differences in efficacy of administered pre-operative Midazolam and Intraoperative IM Ketorolac (traditional) vs. pre-operative Dexmedetomidine alone for pain and emergence delirium management of children undergoing placement of BMTs. The current protocol was changed under the direction of anesthesia and team members who wanted to see what the outcomes of the new management plan were. The plan was a prospective chart review and for this project, 276 patient charts were reviewed, 154 patients received traditional anesthesia treatment and 122 received Precedex. Data analysis indicated that the patients who had received Dexmedetomidine had significantly higher FLACC scores (meaning better pain control) than those who received the traditional therapy. There was no difference in emergence delirium between the two groups.
Primary Outcome
use of dexmedetomidine alone in preoperative period
Interventions
- OTHER Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2023-02-03 |
What the finished NCT05903326 record still lists
NCT05903326 is an observational study that tracks outcomes without assigning an intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT05903326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05903326 about?
NCT05903326 is a clinical study titled "Dexmedetomidine as a Sole Premedication for BMT Placement". There is very little evidence or research documenting any single method of sedation/analgesia for myringotomy tube (BMT) placement as being more effective than others. This was a retrospective chart review conducted to determine if there were significant differences in efficacy of administered pre-o...
What is the current status of trial NCT05903326?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2022-02-11. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05903326?
The interventions under investigation include: Dexmedetomidine (OTHER).
Who is sponsoring clinical trial NCT05903326?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI